F. Bodin

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril

Nicholas J. Holwerda, Roberto Fogari, Philippe Angeli et al. · Journal of Hypertension · 1996 · 125 citations

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study

Richard N. Channick, David B. Badesch, Victor F. Tapson et al. · The Journal of Heart and Lung Transplantation · 2001 · 111 citations

Hypertension, Pulmonary Arterial Hypertension, Cardiovascular Disease +8

Valsartan: Long Term Efficacy and Tolerability Compared to Lisinopril in Elderly Patients with Essential Hypertension

Bremner Ad, MO Baur, Pascale Oddou-Stock et al. · Clinical and Experimental Hypertension · 1997 · 54 citations

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide

G. Hegner, G. Faust, F Freytag et al. · European Journal of Clinical Pharmacology · 1997 · 52 citations

Hypertension, Medicine, Antihypertensive Therapy +6

The DIEP flap breast reconstruction: Starting from scratch in a university hospital

F. Bodin, C. Dissaux, Jean-Christophe Lutz et al. · Annales de Chirurgie Plastique Esthétique · 2015 · 38 citations

Cosmetic Surgery, Soft Tissue Surgery, University Hospital +9